GUIDELINES FOR PERIOPERATIVE FLUID TREATMENT
DOI:
https://doi.org/10.6016/ZdravVestn.1300Keywords:
perioperativno nadomeščanje tekočin pri odraslih, perioperativno nadomeščanje tekočin pri otrocih, tekočine in politravma, tekočine v intenzivni terapijiAbstract
Introduction.The maintainaning of optimal perioperative fluid and electrolyte balance in the perioparative period (before, during and after an operation) is a crucial for anaesthesia and intensive therapy. Fluid treatment interferes with the metabolism and functioning of all organ systems, therefore it is important that the patient gets the right type and quantity of fluid at the right time. Perioperative fluid therapy should be guided by the patient’s condition and type of the operation procedure. In fluid therapy, one should take into consideration the need for fluid maintenance (basal metabolism needs), preoperative fluid loss correction (e.c. duration of preoperative starving, especially in children), and aim for good tissue perfusion with an adequate fluid load. The final goal of fluid replacement is to maintain fluid and electrolyte balance, intravascular volume and consequently cardiovascular stability (adequate cardiac output), organ perfusion and tissue oxygenation. Before, during and after surgery balanced fluids should be used, in order to minimise disturbances to the electrolyte balance.
In our article, literature of perioperative fluid replacement is reviewed. The results of the latest research have provoked a lot of criticism and disagreement about colloids. Only guidelines about crystalloid application are presented.
Conclusions. The latest guidelines for perioperative fluid therapy emphasise the application of balanced intravenous fluids that minimise electrolyte and acid base balance disturbances. It is important to individualise the amount of the intravenous fluid to avoid hyper- or hypovolemia. The correct choice of the type of solution is equally important as any other medication that influences the patient’s outcome.
Downloads
References
Internet: medical-dictionary. the free dictionary.com/milieu+interieur.
Strunden MS, Heckle K, Goetz AE, Reuter DA. Perioperative fluid and volume management: physiological basis, tools and stratrgies. Annals of Intensive Care 2011; 1:2.
Marsh C, Brown J. Perioperative fluid therapy. Anaesthesia and intensive care medicine 2012; 13: 594-597.
Guidet B, Soni N, Della Rocca G, Kozek S, Vallet B, Annane D, James M. A balanced view of balanced solutions. Crit Care 2010;14:325.
Powell-Tuck J, Gosling P, Lobo DN, Allison SP, Carlson GL, Gore M, Lewington AJ, Pearse RM, Mythen MG. British Consensus Guidelines on Intravenous Fluid Therapy for Adult Surgical Patients; GIFTASUP. 2011.
Allison S. Fluid, electrolytes and nutrition. Clin Med. 2004;4:573-8.
Doherty M, Buggy DJ. Intraoperative fluids: how much is too much? BJA 2012;109:69-79.
Chappel D, Jacob M, Hofmann-Kiefer K, Conzen P, Rehm M: A rational approach to perioperative fluid management. Anesthesiology 2008, 109:723-40.
Jacob M, Saller T, Chappell D, Rehm M, Welsch U, Becker BF. Physiological levels of A-, B- and C- type natriuretic peptide shed the endothelial glycocalyx and enhance vascular permeability. Basic Res Cardiol 2013;108:347.
Girish PJ. Intraoperative fluid management. Z dne 10.9.2013; dostopno na: http://www.uptodate.com/contents/intraoperative-fluid-management.
Westphal M, James MF, Kozek-Langenecker S, Stocker R, Guidet B, Van Aken H. Hydroxyethyl starches: different products-different effects. Anesthesiology 2009;111:187-202.
Van Der Linden P, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesth Analg 2013;116:35-48.
Kozek-Langenecker SA. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 2005;103:654-60.
Hahn RG. Volume kinetics for infusion fluids. Anesthesiology 2010;113:470-81.
Lambert KG, Wakim JH, Lambert NE. Preoperative bolus and reduction of postoperative nausea and vomiting in patients undergoing laparoscopic gynecologis surgery. ANNA J 2009;77:110-4.
Pearse RM, Ackland GL. Perioperative fluid therapy. BMJ 2012; 26:344.
Wilson J, Woods I, Fawcett J, Whall R, Dibb W, Morris C, McManus E. Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery. BMJ 1999;24:318:1099-103.
Sinclair S, James S, Singer M. Intraoperative intravascular volume optimisation and length of hospital stay after repair of proximal femoral fracture: randomised controlled trial. BMJ 1997;11:315:909-12.
Lobo DN, Bjarnason K, Field J, Rowlands BJ, Allison SP. Changes in weight, fluid balance and serum albumin in patients referred for nutritional support. Clin Nutr 1999;18:197-201.
Lowell JA, Schifferdecker C, Driscoll DF, Benotti PN, Bistrian BR. Postoperative fluid overload: not a benign problem. Crit Care Med 1990;18:728-33.
Nisanevich V, Felsenstein I, Almogy G, Weissman C, Einav S, Matot I. Effect of intraoperative fluid management on outcome after intraabdominal surgery. Anesthesiology 2005;103:25-32.
Holte K, Sharrock NE, Kehlet H. Pathophysiology and clinical implications of perioperative fluid excess. Br J Anaesth 2002;89:622-32.
Mayberry JC, Welker KJ, Goldman RK, Mullins RJ. Mechanism of acute ascites formation after trauma resuscitation. Arch Surg 2003;138:773-6.
Balogh Z, McKinley BA, Cocanour CS, Kozar RA, Valdivia A, Sailors RM, Moore FA. Supranormal trauma resuscitation causes more cases of abdominal compartment syndrome. Arch Surg 2003;138:637-42; discussion 642-3.
Mythen MG, Swart M, Acheson N, Crawford R, Jones K, Kuper M, McGrath J, Horgan A. Perioperative fluid management: Consensus statement from the enhanced recovery partnership. Perioperative medicine 2012; 1:2.
Hausel J, Nygren J, Lagerkranser M, Hellström PM, Hammarqvist F, Almström C, Lindh A, Thorell A, Ljungqvist OA carbohydrate-rich drink reduces preoperative discomfort in elective surgery patients. Anesth Analg 2001;93:1344-50.
Soop M, Nygren J, Myrenfors P, Thorell A, Ljungqvist O. Preoperative oral carbohydrate treatment attenuates immediate postoperative insulin resistance. Am J Physiol Endocrinol Metab 2001;280:576-83.
Pearse RM, Harrison DA, James P, Watson D, Hinds C, Rhodes A, Grounds RM, Bennett ED. Identification and characterisation of the high-risk surgical population in the United Kingdom. Crit Care 2006;10:81.
Jhanji S, Dawson J, Pearse RM. Cardiac output monitoring: basic science and clinical application. Anaesthesia 2008; 63:172-81.
Kheterpal S, Tremper KK, Englesbe MJ, O'Reilly M, Shanks AM, Fetterman DM, Rosenberg AL, Swartz RD. Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology 2007;107:892-902.
Corcoran T, Rhodes JE, Clarke S, Myles PS, Ho KM. Perioperative fluid management strategies in major surgery: a stratified meta-analysis. Anesth Analg 2012;114:640-51.
Bennett-Guerrero E, Welsby I, Dunn TJ, Young LR, Wahl TA, Diers TL, Phillips-Bute BG, Newman MF, Mythen MG. The use of a postoperative morbidity survey to evaluate patients with prolonged hospitalization after routine, moderate-risk, elective surgery. Anesth Analg 1999; 89:514-9.
Nisanevich V, Felsenstein I, Almogy G, Weissman C, Einav S, Matot I. Effect of intraoperative fluid management on outcome after intraabdominal surgery. Anesthesiology 2005;103:25-32.
Shepherd SJ, Pearse RM. Role of central and mixed venous oxygen saturation measurement in perioperative care. Anesthesiology 2009;111:649-56.
Pearse RM, Holt PJ, Grocott MP. Managing perioperative risk in patients undergoing elective non-cardiac surgery. BMJ 2011; 343:d5759.
Arieff AI, Ayus JC, Fraser CL. Hyponatraemia and death or permanent brain demage in healthy children. BMJ 1992; 304:1218-22.
Holliday MA, Segar WE. The maintenance need for water in parenteral fluid therapy. Pediatrics 1957; 19: 823-32.
Ayus JC, Achinger SG, Arieff A. Brain cell volume regulation in hyponatremia: role of sex, age, vasopressin and hipoxia. Am J Physiol renal Physiol 2008;295:619-24.
Murat I, Dubois MC. Perioperative fluid therapy in pediatrics. Paediatr Anesth 2008;18:363-70.
Berry F. Practical aspects of fluid and electrolite therapy. In: Berry F ed. Anesthetic Menagement of Difficult and routine Pediatric Patients. New York: Churchill Livingstone,1986:107-35.
Chappell D, Jacob M, Hofmann-Kiefer K, et.all. A rational approach to perioperative fluid management. Anesthesiology 2008;109:723-40
Bailey AG, McNaull PP, Jooste E, Tuchmann JB. Perioperative crystalloid and colloid fluid menagement in children: where are we and how did we get here? Anesth Analg 2010;110:375-90.
7. Sümpelmann R, Becke K, Crean P, Jöhr M, Lönnqvist PA, Strauss JM, Veyckemans F. German Scientific Working Group for Paediatric Anaesthesia. European consensus statement for intraoperative fluid therapy in children. Eur J Anaesthesiol 2011;28(9):637-9.
Sümpelmann R, Mader T, Dennhardt N, Witt L, Eich C, Osthaus WA. A novel isotonic balanced electrolyte solution with 1% glucose for intraoperative fluid therapy in neonates: results of a prospective multicentre observational postauthorisation safety study (PASS). Paediatr Anaesth 2011;21:1114-8.
Welborn L, McGill W, Hannallah R, Nisselson C, Ruttimann U, Hicks J. Perioperative blood glucose concentrations in pediatric outpatients. Anesthesiology 1986;65:543-7.
Bougle A, Harrois A, Duranteau J. Resuscitative strategies in traumatic hemorrhagic shock. Annals of Intensive Care 2013;3:1.
Kroll W, Polz W, Schimetta W. ["Small volume resuscitation"--does it open new possibilities in the treatment of hypovolemic shock?]. Wien Klin Wochenschr 1994;106:8-14.
Kroll W, Polz W, Colombo T, Steindorfer P. [Degree of substitution and volume expanding effect of various medium molecular weight hydroxyethyl starch solutions]. Wien Klin Wochenschr 1994;106:416-21.
Jacob M, Rehm M, Orth V, et al. Exakte Messung des Volumeneffektes von 6%iger Hydroxyethylstärke 130/0,4 (Voluven®) während präoperativer akuter normovolämer Hämodilution. Der Anaesthesist 2003;52:896-904.
Rehm M, Haller M, Orth V, et al. Changes in blood volume and hematocrit during acute preoperative volume loading with 5% albumin or 6% hetastarch solutions in patients before radical hysterectomy. Anesthesiology 2001;95:849-56.
Chappell D, Jacob M, Hofmann-Kiefer K, et al. A rational approach to perioperative fluid management. Anesthesiology 2008;109:723-40.
James MFM, Michell WL, Joubert IA, et al. Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). British Journal of Anaesthesia 2011;107:693-702.
Guidet B, Martinet O, Boulain T, Philippart F, Poussel JF, Maizel J et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Crit Care 2012;16:R94.
Skhirtladze K, Base EM, Lassnigg A, et al. Comparison of the effects of albumin 5%, hydroxyethyl starch 130/0.4 6%, and Ringer's lactate on blood loss and coagulation after cardiac surgery. British Journal of Anaesthesia 2013.
Adamson RH, Lenz JF, Zhang X, et al. Oncotic pressures opposing filtration across non-fenestrated rat microvessels. The Journal of Physiology 2004;557:889-907.
Levick JR, Michel CC. Microvascular fluid exchange and the revised Starling principle. Cardiovascular Research 2010;87:198-210.
Woodcock TE, Woodcock TM. Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy. British Journal of Anaesthesia 2012;108:384-94.
Myburgh J, Bellomo R, Cass A. The Crystalloid versus Hydroxyethyl Starch Trial: protocol for a multi-centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Med 2011;37:816-23.
Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A et al. 6S Trial Group; Scandinavian Critical Care Trials Group. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012;367:124-34.
Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D et al. CHEST Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012;367:1901-11.
Müller R, Haase N, Wetterslev J, Perner A. Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post-hoc analyses of a randomised trial. Intensive Care Med 2013;39:1963-71.
Annane D, Siami S, Jaber S, Martin C, Elatrous S, Declère AD et al. Effects of Fluid Resuscitation With Colloids vs Crystalloids on Mortality in Critically Ill Patients Presenting With Hypovolemic Shock: The CRISTAL Randomized Trial. JAMA 2013;310:1809-17.
Deusch E, Gamsjager T, Kress HG, Kozek-Langenecker SA. Binding of hydroxyethyl starch molecules to the platelet surface. Anesth Analg 2003;97:680-3.
Mittermayr M, Streif W, Haas T, et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg 2007;105:905-17, table.
Kozek-Langenecker SA. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 2005;103:654-60.
Kind SL, Spahn-Nett GH, Emmert MY, et al. Is Dilutional Coagulopathy Induced by Different Colloids Reversible by Replacement of Fibrinogen and Factor XIII Concentrates? Anesth Analg 2013;117:1063-71.
Legendre C, Thervet E, Page B, et al. Hydroxyethylstarch and osmotic-nephrosis- like lesions in kidney transplantation. The Lancet 1993;342:248-9.
Feldheiser A, Pavlova V, Bonomo T, et al. Balanced crystalloid compared with balanced colloid solution using a goal-directed haemodynamic algorithm. British Journal of Anaesthesia 2013;110:231-40.
Gurbuz HA, Durukan AB, Salman N, et al. Hydroxyethyl starch 6%, 130/0.4 vs. a balanced crystalloid solution in cardiopulmonary bypass priming: a randomized, prospective study. Journal of Cardiothoracic Surgery 2013;8:71.
Van der Linden P, De VA, Hofer A, et al. Six Percent Hydroxyethyl Starch 130/0.4 (Voluven(R)) versus 5% Human Serum Albumin for Volume Replacement Therapy during Elective Open-heart Surgery in Pediatric Patients. Anesthesiology 2013.
Akkucuk FG, Kanbak M, Ayhan B, et al. The Effect of HES (130/0.4) Usage as the Priming Solution on Renal Function in Children Undergoing Cardiac Surgery. Ren Fail 2012;35:210-5.
Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2011;CD000567.
Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2012;6:CD000567.
Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2013;2:CD000567.
Hartog CS, Welte T, Schlattmann P, Reinhart K. Fluid Replacement With Hydroxyethyl Starch in Critical Care - a Reassessment. Dtsch Arztebl International 2013;110:443-50.
Nicolai H, Anders P, Louise IH, et al. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 2013;346.
Patel A, Waheed U, Brett S. Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis. Intensive Care Med 2013;39:811-22.
Zarychanski R, Abou-Setta AM, Turgeon AF. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: A systematic review and meta-analysis. JAMA 2013;309:678-88.
Gattas D, Dan A, Myburgh J, et al. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med 2013;39:558-68.
Wiedermann CJ, Dunzendorfer S, Gaioni LU, et al. Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials. Crit Care 2010;14:R191.
Martin C, Jacob M, Vicaut E, et al. Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology 2013;118:387-94.
Van der Linden P, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesth Analg 2013;116:35-48.
Chappell D, Jacob M. Hydroxyethyl starch - the importance of being earnest. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2013;21:61.
Spahn DR, Bouillon B, Cerny V, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013;17:R76.
Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013;30:270-382.
Simon B, Ebert J, Bokhari F, et al. Management of pulmonary contusion and flail chest: an Eastern Association for the Surgery of Trauma practice management guideline. J Trauma Acute Care Surg 2012;73:S351-S361.
Leibson CL, Brown AW, Ransom JE, et al. Incidence of traumatic brain injury across the full disease spectrum: a population-based medical record review study. Epidemiology 2011;22:836-44.
McHugh GS, Engel DC, Butcher I, et al. Prognostic value of secondary insults in traumatic brain injury: results from the IMPACT study. J Neurotrauma 2007;24:287-93.
van LN, Lingsma HF, Perel P, et al. Prognostic value of major extracranial injury in traumatic brain injury: an individual patient data meta-analysis in 39,274 patients. Neurosurgery 2012;70:811-8.
Chowdhury T, Cappellani RB, Schaller B, Daya J. Role of colloids in traumatic brain injury: Use or not to be used? Journal of Anaesthesiology Clinical Pharmacology 2013;29:299-302.
Myburgh J, Cooper DJ, S. Saline or Albumin for Fluid Resuscitation in Patients with Traumatic Brain Injury. N Engl J Med 2007;357:874-84.
Cooper DJ, Myburgh J, Heritier S, et al. Albumin resuscitation for traumatic brain injury: is intracranial hypertension the cause of increased mortality? J Neurotrauma 2013;30:512-8.
Reinhart K, Perner A, Sprung CL, et al. Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med 2012;38:368-83.
Lukaszewicz AC, Soyer B, Payen D. Water, water, everywhere: sodium and water balance and the injured brain. Curr Opin Anaesthesiol 2011;24:138-43.
Lescot T, Degos V, Zouaoui A, et al. Opposed effects of hypertonic saline on contusions and noncontused brain tissue in patients with severe traumatic brain injury. Crit Care Med 2006;34:3029-33.
Zeng HK, Wang QS, Deng YY, et al. Hypertonic saline ameliorates cerebral edema through downregulation of aquaporin-4 expression in the astrocytes. Neuroscience 2010;166:878-85.
Rockswold SB, Rockswold GL, Zaun DA, et al. A prospective, randomized clinical trial to compare the effect of hyperbaric to normobaric hyperoxia on cerebral metabolism, intracranial pressure, and oxygen toxicity in severe traumatic brain injury. J Neurosurg 2010;112:1080-94.
Bulger EM, May S, Brasel KJ. Out-of-hospital hypertonic resuscitation following severe traumatic brain injury: A randomized controlled trial. JAMA 2010;304:1455-64.
Bulger EM, May S, Kerby JD, et al. Out-of-hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Ann Surg 2011;253:431-41.
Roquilly A, Loutrel O, Cinotti R, et al. Balanced versus chloride-rich solutions for fluid resuscitation in brain-injured patients: a randomised double-blind pilot study. Critical Care 2013;17:R77.
Greene N, Bhananker S, Ramaiah R. Vascular access, fluid resuscitation, and blood transfusion in pediatric trauma. Int J Crit Illn Inj Sci 2012;2:135-42.
Wills BA, Dung NM, Loan HT, et al. Comparison of Three Fluid Solutions for Resuscitation in Dengue Shock Syndrome. N Engl J Med 2005;353:877-89.
Maitland K, Kiguli S, Opoka RO, et al. Mortality after Fluid Bolus in African Children with Severe Infection. N Engl J Med 2011;364:2483-95.
Maitland K, George E, Evans J, et al. Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial. BMC Medicine 2013;11:68.
Myburgh J, Finfer S. Causes of death after fluid bolus resuscitation: new insights from FEAST. BMC Medicine 2013;11:67.
Tuggle DW, Kuhn MA, Jones SK, et al. Hyperglycemia and Infections in Pediatric Trauma Patients. The American Surgeon 2008;74:195-8.
Dellinger RP et al. Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 Intensive Care Med 2013;39:165-228.
Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M et al. German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-39.
Priporočilo PRAC EMA z dne 13.6.2013 dostopno na: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Solution_for_infusion_containing_hydroxyethyl_starch/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500144448.pdf
Priporočila PRAC EMA z dne 11.10.2013 dostopno na: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Solutions_for_infusion_containing_hydroxyethyl_starch/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500151963.pdf
Priporočila FDA z dne 11.6.2013 dostopno na http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicaProducts/ucm358349.htm
Müller RG, Haase N, Wetterslev J, Perner A. Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post-hoc analyses of a randomised trial. Intensive Care Med 2013;39:1963-71.
Puyana JC Resuscitation of hypovolemic shock. In: Fink M, Abraham E, Vincent JL, Kochanek PM, eds. Textbook of Critical Care. 5th ed. Philadelphia: Elsevier Saunders, 2005:1939–40.
Hartog CS, Kohl M, Reinhart K. A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) in resuscitation: safety not adequately addressed. Anesth Analg 2011;112:635-45.
Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 2011;39:259-65.
Sadaka F, Juarez M, Naydenov S, O'Brien J. Fluid Resuscitation in Septic Shock: The Effect of Increasing Fluid Balance on Mortality. J Intensive Care Med. 2013 Feb 27. [Epub ahead of print] PubMed PMID: 23753235.
Meybohm P, Van Aken H, De Gasperi A, De Hert S, Della Rocca G, Girbes AR et al. Reevaluating currently available data and suggestions for planning randomised controlled studies regarding the use of hydroxyethyl-starch in critically ill patients – a multidisciplinary statement. Crit Care 2013;17:R166.
Kellum JA, Bellomo R, Ronco C. The concept of acute kidney injury and the RIFLE criteria. Contrib Nephrol 2007;156:10-16.
Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A, Acute Kidney Injury Network: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R31.
Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R; SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004;350:2247-56.
SAFE Study Investigators, Finfer S, McEvoy S, Bellomo R, McArthur C, Myburgh J, Norton R. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 2011;37:86-96.
Delaney AP, Dan A, McCaffrey J, Finfer S. The role of albumin as a meta-analysis. Crit Care Med 2011;39:386-91.
Downloads
Published
Issue
Section
License
The Author transfers to the Publisher (Slovenian Medical Association) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Slovenian Medical Association) has the right to transfer the rights of acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
